Company Filing History:
Years Active: 2018-2020
Title: Innovator Spotlight: Christopher Schaber
Introduction
Christopher Schaber is an accomplished inventor based in Princeton, NJ. With a portfolio of three patents, he has made significant contributions to the fields of synthetic biology and immunology. As a vital member of Soligenix, Inc., Schaber continues to push the boundaries of innovation through his pioneering work.
Latest Patents
Schaber's latest patents showcase his commitment to advancing medical science. One of his notable inventions is the "Systems and methods for producing synthetic hypericin." This patent details improved systems for producing synthetic hypericin at high volume and purity. Specifically, it involves a process that utilizes continuous flow micro-reactors for the irradiation step, resulting in a remarkable synthetic yield of 30-100% of the dry product.
Another groundbreaking patent is the "Multivalent stable vaccine composition and methods of making same." This invention describes a stable immunogenic composition that elicits a robust and durable immune response. Notably, it is capable of generating a measurable increase in neutralizing antibodies for at least 200 days post-administration. The composition includes at least one antigen from a ribosome inactivating protein and at least one toxin derived from bacterial spores, highlighting Schaber's innovative approach to vaccine development.
Career Highlights
Throughout his career, Schaber has played an integral role at Soligenix, Inc., focusing on innovative solutions that address critical health challenges. His work emphasizes the development of new manufacturing processes and immunogenic compositions that improve treatment efficacy and patient outcomes. Schaber's dedication to his field is evident in the transformative nature of his inventions.
Collaborations
Collaboration has been key to Schaber's success. He has worked alongside talented colleagues such as Rasappa Arumugham and Holger Rauter. Together, they contribute to a vibrant research environment at Soligenix, Inc., fostering innovation and advancing the company’s mission to create effective healthcare solutions.
Conclusion
Christopher Schaber stands out as a prolific inventor whose work in synthetic hypericin and vaccine development continues to make a significant impact. His innovative spirit and dedication to improving healthcare through science exemplify the role of inventors in shaping the future. Schaber's contributions highlight the importance of perseverance and collaboration in driving advancements in medicine.